{"id":"https://openalex.org/W7220853298","doi":"https://doi.org/10.3389/fphar.2026.1913235","title":"Comparative real-world pharmacovigilance analysis of adverse event signals associated with six approved CAR-T products using the FAERS database","display_name":"Comparative real-world pharmacovigilance analysis of adverse event signals associated with six approved CAR-T products using the FAERS database","publication_year":2026,"publication_date":"2026-10-07","ids":{"openalex":"https://openalex.org/W7220853298","doi":"https://doi.org/10.3389/fphar.2026.1913235","pmid":"https://pubmed.ncbi.nlm.nih.gov/42908664","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13683057"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2026.1913235","doi":"https://doi.org/10.3389/fphar.2026.1913235","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1913235","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1913235/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1913235/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5157827916","display_name":"Shengyuan Xiao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I91935597","display_name":"University of South China","ror":"https://ror.org/03mqfn238","country_code":"CN","type":"education","lineage":["https://openalex.org/I91935597"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shengyuan Xiao","raw_affiliation_strings":["Hengyang Medical School, University of South China","Hunan Provincial Key Laboratory of Basic and Clinical Pharmacological Research of Gastrointestinal Cancer, Department of Pharmacy, Institute of Pharmacy and Pharmacology, The Second Affiliated Hospital, University of South China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hengyang Medical School, University of South China","institution_ids":["https://openalex.org/I91935597"]},{"raw_affiliation_string":"Hunan Provincial Key Laboratory of Basic and Clinical Pharmacological Research of Gastrointestinal Cancer, Department of Pharmacy, Institute of Pharmacy and Pharmacology, The Second Affiliated Hospital, University of South China","institution_ids":["https://openalex.org/I91935597"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100414198","display_name":"Ying Li","orcid":"https://orcid.org/0000-0002-3236-6870","observed_orcids":["https://orcid.org/0000-0002-3236-6870"]},"institutions":[{"id":"https://openalex.org/I91935597","display_name":"University of South China","ror":"https://ror.org/03mqfn238","country_code":"CN","type":"education","lineage":["https://openalex.org/I91935597"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ying Li","raw_affiliation_strings":["Hengyang Medical School, University of South China","Hunan Provincial Key Laboratory of Basic and Clinical Pharmacological Research of Gastrointestinal Cancer, Department of Pharmacy, Institute of Pharmacy and Pharmacology, The Second Affiliated Hospital, University of South China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hengyang Medical School, University of South China","institution_ids":["https://openalex.org/I91935597"]},{"raw_affiliation_string":"Hunan Provincial Key Laboratory of Basic and Clinical Pharmacological Research of Gastrointestinal Cancer, Department of Pharmacy, Institute of Pharmacy and Pharmacology, The Second Affiliated Hospital, University of South China","institution_ids":["https://openalex.org/I91935597"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5157875653","display_name":"Hui Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I91935597","display_name":"University of South China","ror":"https://ror.org/03mqfn238","country_code":"CN","type":"education","lineage":["https://openalex.org/I91935597"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Hui Wang","raw_affiliation_strings":["Hengyang Medical School, University of South China","Hunan Provincial Key Laboratory of Basic and Clinical Pharmacological Research of Gastrointestinal Cancer, Department of Pharmacy, Institute of Pharmacy and Pharmacology, The Second Affiliated Hospital, University of South China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hengyang Medical School, University of South China","institution_ids":["https://openalex.org/I91935597"]},{"raw_affiliation_string":"Hunan Provincial Key Laboratory of Basic and Clinical Pharmacological Research of Gastrointestinal Cancer, Department of Pharmacy, Institute of Pharmacy and Pharmacology, The Second Affiliated Hospital, University of South China","institution_ids":["https://openalex.org/I91935597"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5157872275","display_name":"Longcai Tong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I91935597","display_name":"University of South China","ror":"https://ror.org/03mqfn238","country_code":"CN","type":"education","lineage":["https://openalex.org/I91935597"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Longcai Tong","raw_affiliation_strings":["Hunan Provincial Key Laboratory of Basic and Clinical Pharmacological Research of Gastrointestinal Cancer, Department of Pharmacy, Institute of Pharmacy and Pharmacology, The Second Affiliated Hospital, University of South China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hunan Provincial Key Laboratory of Basic and Clinical Pharmacological Research of Gastrointestinal Cancer, Department of Pharmacy, Institute of Pharmacy and Pharmacology, The Second Affiliated Hospital, University of South China","institution_ids":["https://openalex.org/I91935597"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5157826727","display_name":"Rong Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I91935597","display_name":"University of South China","ror":"https://ror.org/03mqfn238","country_code":"CN","type":"education","lineage":["https://openalex.org/I91935597"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Rong Li","raw_affiliation_strings":["Hengyang Medical School, University of South China","Hunan Provincial Key Laboratory of Basic and Clinical Pharmacological Research of Gastrointestinal Cancer, Department of Pharmacy, Institute of Pharmacy and Pharmacology, The Second Affiliated Hospital, University of South China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hengyang Medical School, University of South China","institution_ids":["https://openalex.org/I91935597"]},{"raw_affiliation_string":"Hunan Provincial Key Laboratory of Basic and Clinical Pharmacological Research of Gastrointestinal Cancer, Department of Pharmacy, Institute of Pharmacy and Pharmacology, The Second Affiliated Hospital, University of South China","institution_ids":["https://openalex.org/I91935597"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5157826727","https://openalex.org/A5157875653"],"corresponding_institution_ids":["https://openalex.org/I91935597"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.75163337,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":"1913235","last_page":"1913235"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.004699999932199717,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10902","display_name":"Complementary and Alternative Medicine Studies","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.9639999866485596},{"id":"https://openalex.org/keywords/adverse-event-signals","display_name":"adverse event signals","score":0.8360000252723694},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.8820000290870667},{"id":"https://openalex.org/keywords/fda-adverse-event-reporting-system","display_name":"FDA Adverse Event Reporting System","score":0.722000002861023},{"id":"https://openalex.org/keywords/comparative-drug-safety","display_name":"drug safety comparison","score":0.5590000152587891},{"id":"https://openalex.org/keywords/cytokine-release-syndrome","display_name":"cytokine release syndrome","score":0.8679999709129333},{"id":"https://openalex.org/keywords/immune-effector-cell-associated-neurotoxicity-syndrome","display_name":"immune effector cell-associated neurotoxicity syndrome","score":0.8550000190734863},{"id":"https://openalex.org/keywords/neurotoxicity","display_name":"neurotoxicity","score":0.9940000176429749},{"id":"https://openalex.org/keywords/tisagenlecleucel","display_name":"tisagenlecleucel","score":0.9409999847412109},{"id":"https://openalex.org/keywords/axicabtagene-ciloleucel","display_name":"axicabtagene ciloleucel","score":1.0},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.7020000219345093},{"id":"https://openalex.org/keywords/disproportionality-analysis","display_name":"disproportionality analysis","score":0.5559999942779541}],"concepts":[{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.8935999870300293},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8366000056266785},{"id":"https://openalex.org/C2777105317","wikidata":"https://www.wikidata.org/wiki/Q4686710","display_name":"Adverse Event Reporting System","level":3,"score":0.8309000134468079},{"id":"https://openalex.org/C77088390","wikidata":"https://www.wikidata.org/wiki/Q8513","display_name":"Database","level":1,"score":0.5004000067710876},{"id":"https://openalex.org/C23276603","wikidata":"https://www.wikidata.org/wiki/Q158230","display_name":"Pharmacoepidemiology","level":3,"score":0.4779999852180481},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.43869999051094055},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3871999979019165},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.3093999922275543},{"id":"https://openalex.org/C2779662365","wikidata":"https://www.wikidata.org/wiki/Q5416694","display_name":"Event (particle physics)","level":2,"score":0.2833000123500824},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.2736999988555908},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.26669999957084656}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fphar.2026.1913235","doi":"https://doi.org/10.3389/fphar.2026.1913235","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1913235","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1913235/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13683057","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13683057/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13683057/pdf/fphar-17-1913235.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Pharmacol","raw_type":"Text"},{"id":"pmid:42908664","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42908664","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:984be74787fa4100b3d68bfcbd10f89b","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/984be74787fa4100b3d68bfcbd10f89b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2026.1913235","doi":"https://doi.org/10.3389/fphar.2026.1913235","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1913235","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1913235/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7220853298.pdf","grobid_xml":"https://content.openalex.org/works/W7220853298.grobid-xml"},"referenced_works_count":21,"referenced_works":["https://openalex.org/W1988100739","https://openalex.org/W2015487160","https://openalex.org/W2158299492","https://openalex.org/W2773804840","https://openalex.org/W2903062212","https://openalex.org/W2905654445","https://openalex.org/W3014583893","https://openalex.org/W3037830886","https://openalex.org/W3082855561","https://openalex.org/W3093752130","https://openalex.org/W3133229959","https://openalex.org/W3162374648","https://openalex.org/W3176532045","https://openalex.org/W4200287748","https://openalex.org/W4384923413","https://openalex.org/W4391261634","https://openalex.org/W4401154877","https://openalex.org/W4401337690","https://openalex.org/W4407680725","https://openalex.org/W4414541174","https://openalex.org/W7160269173"],"related_works":["https://openalex.org/W4401337690","https://openalex.org/W6920781969","https://openalex.org/W7214779003","https://openalex.org/W7160659794","https://openalex.org/W7166813328","https://openalex.org/W7166562889","https://openalex.org/W7217003045","https://openalex.org/W6939407151","https://openalex.org/W4417002477","https://openalex.org/W7106536793"],"abstract_inverted_index":{"Objective:":[0],"Although":[1],"several":[2,189],"CAR-T":[3,28,51,246,283],"products":[4,29,70,284],"have":[5],"been":[6],"approved":[7,27],"for":[8,50,57],"hematologic":[9,258],"malignancies,":[10],"their":[11,234],"post-marketing":[12],"adverse-event":[13],"reporting":[14,37,169,247],"patterns":[15],"may":[16],"not":[17,144],"be":[18],"interchangeable.":[19],"This":[20],"study":[21],"compared":[22,118],"FAERS-derived":[23],"positive":[24],"signals":[25,83,116,159,269],"across":[26,160,237],"to":[30,45,68,146],"distinguish":[31],"recurrent":[32],"class-related":[33],"toxicities":[34],"from":[35,42],"product-skewed":[36,262],"patterns.":[38,264],"Methods:":[39],"FAERS":[40,276],"reports":[41],"Q1":[43],"2014":[44],"Q2":[46],"2025":[47],"were":[48,55,66,84,117,128,139,143,226],"reviewed":[49],"products.":[52,163,238],"Demographic":[53],"characteristics":[54],"summarized":[56],"seven":[58],"products,":[59],"whereas":[60,186],"PT-":[61],"and":[62,80,89,112,122,142,165,172,183,199,212,222,224,257,275,285],"SOC-level":[63],"signal":[64,73,135,241,263],"analyses":[65],"restricted":[67],"six":[69,162],"with":[71,261],"sufficient":[72],"data:":[74],"Breyanzi,":[75],"Kymriah,":[76],"Tecartus,":[77],"Yescarta,":[78],"Abecma,":[79],"Carvykti.":[81],"Positive":[82],"detected":[85],"using":[86],"ROR,":[87],"PRR,":[88],"BCPNN":[90],"algorithms.":[91],"After":[92],"predefined":[93,134],"exclusion":[94],"of":[95,170],"nonclinical":[96],"or":[97,101,105,109],"non-AE":[98],"terms,":[99,103,107,111,114],"indication-":[100],"disease-progression-related":[102],"procedure-":[104],"investigation-related":[106],"efficacy-":[108],"persistence-related":[110],"product-quality-related":[113],"eligible":[115],"at":[119],"the":[120,133,156,216,228],"PT":[121],"SOC":[123,217],"levels.":[124],"Nonspecific":[125],"MedDRA-coded":[126],"PTs":[127,191],"retained":[129],"if":[130],"they":[131,138],"met":[132],"criteria,":[136],"but":[137,233],"interpreted":[140],"descriptively":[141],"used":[145],"define":[147],"product-level":[148],"profile":[149],"labels.":[150],"Results:":[151],"CRS":[152],"was":[153,176],"consistently":[154],"among":[155,227],"leading":[157],"PT-level":[158],"all":[161],"Yescarta":[164],"Tecartus":[166],"showed":[167,188,203,243],"higher":[168],"ICANS":[171],"neurotoxicity-related":[173],"PTs.":[174],"Kymriah":[175],"more":[177],"strongly":[178],"represented":[179,231],"by":[180],"infection-,":[181],"immune-,":[182],"hematologic-related":[184],"signals,":[185],"Carvykti":[187],"neurologic":[190],"including":[192,209],"Parkinsonism,":[193],"cranial":[194],"nerve":[195],"paralysis,":[196,198],"facial":[197],"Bell's":[200],"palsy.":[201],"Abecma":[202],"relatively":[204],"high-ranking":[205],"systemic":[206],"symptom-related":[207],"PTs,":[208],"fatigue,":[210],"headache,":[211],"decreased":[213],"appetite.":[214],"At":[215],"level,":[218],"nervous":[219],"system":[220],"disorders":[221],"infections":[223],"infestations":[225],"most":[229],"frequently":[230],"categories,":[232],"proportions":[235],"differed":[236],"Conclusion:":[239],"FAERS-based":[240],"detection":[242],"a":[244],"common":[245],"backbone":[248],"centered":[249],"on":[250],"CRS,":[251],"ICANS/neurotoxicity,":[252],"hypotension,":[253],"pyrexia,":[254],"infection-related":[255],"events,":[256,259],"together":[260],"These":[265],"findings":[266],"represent":[267],"disproportionality":[268],"rather":[270],"than":[271],"comparative":[272],"safety":[273],"rankings,":[274],"data":[277],"cannot":[278],"establish":[279],"causal":[280],"relationships":[281],"between":[282],"adverse":[286],"events.":[287]},"counts_by_year":[],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2026-10-08T00:00:00"}